Silke Nuber

5PUBLICATIONS
13CO-AUTHORS
Pharmaceutical delivery technologiesNeurology and neuromuscular diseasesGene mappingPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 30, 2026
From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson's disease therapy development.

|Feb 29, 2024
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypes.

Silke Nuber, Xiaoqun Zhang, Thomas D McCaffery

|Jul 30, 2021
Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.

Kelly E Glajch, Tim E Moors, Yi Chen

|Sep 30, 2020
A Stearoyl-Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α-Synuclein Mice.

Silke Nuber, Alice Y Nam, Molly M Rajsombath

Pageof 1

Frequent Collaborators

3 joint publications

Ulf Dettmer

3 joint publications

Dennis J Selkoe

2 joint publications

Andreas Weihofen

2 joint publications

Per Svenningsson